Daily angina documentation versus subsequent recall: development of a symptom smartphone app

Nowbar, Alexandra N. and Howard, James P. and Shun-Shin, Matthew J. and Rajkumar, Christopher and Foley, Michael and Basu, Arunima and Goel, Akshit and Patel, Sapna and Adnan, Ahmer and Beattie, Catherine J. and Keeble, Thomas R. and Sohaib, Afzal and Collier, David and McVeigh, Patrick and Harrell, Frank E. and Francis, Darrel P. and Al-Lamee, Rasha K. (2022) Daily angina documentation versus subsequent recall: development of a symptom smartphone app. European Heart Journal - Digital Health. ISSN 2634-3916

[img]
Preview
Text
Published Version
Available under the following license: Creative Commons Attribution Non-commercial.

Download (668kB) | Preview
Official URL: https://doi.org/10.1093/ehjdh/ztac015

Abstract

Aims: The traditional approach to documenting angina outcomes in clinical trials is to ask the patient to recall their symptoms at the end of a month. With the ubiquitous availability of smartphones and tablets, daily contemporaneous documentation might be possible. Methods and results: The ORBITA-2 symptom smartphone app was developed with a user-centred iterative design and testing cycle involving a focus group of previous ORBITA participants. The feasibility and acceptability were assessed in an internal pilot of participants in the ongoing ORBITA-2 trial. Seven days of app entries by ORBITA-2 participants were compared with subsequent participant recall at the end of the 7-day period. The design focus group tested a prototype app. They reported that the final version captured their symptoms and was easy to use. In the completion assessment group, 141 of 142 (99%) completed the app in full and 47 of 141 (33%) without reminders. In the recall assessment group, 29 of 29 (100%) participants said they could recall the previous day’s symptoms, and 82% of them recalled correctly. For 2 days previously, 88% said they could recall and of those, 87% recalled correctly. The proportion saying they could recall their symptoms fell progressively thereafter: 89, 67, 61, 50%, and at 7 days, 55% (P < 0.001 for trend). The proportion of recalling correctly also fell progressively to 55% at 7 days (P = 0.04 for trend). Conclusion: Episode counts of angina are difficult to recall after a few days. For trials such as ORBITA-2 focusing on angina, daily symptom collection via a smartphone app will increase the validity of the results.

Item Type: Journal Article
Keywords: angina, symptom app, recall bias, mobile health, feasibility, patient involvement
Faculty: Faculty of Health, Education, Medicine & Social Care
Depositing User: Ian Walker
Date Deposited: 21 Jun 2022 10:48
Last Modified: 01 Jul 2022 12:03
URI: https://arro.anglia.ac.uk/id/eprint/707699

Actions (login required)

Edit Item Edit Item